HPV vaccination and sexual health in France: Empowering girls to decide.


Journal

Vaccine
ISSN: 1873-2518
Titre abrégé: Vaccine
Pays: Netherlands
ID NLM: 8406899

Informations de publication

Date de publication:
22 03 2019
Historique:
received: 09 10 2018
revised: 30 01 2019
accepted: 05 02 2019
pubmed: 28 2 2019
medline: 13 8 2020
entrez: 28 2 2019
Statut: ppublish

Résumé

Vaccination coverage against HPV in France is among the lowest in the industrialized world, although the public authorities have recently become aware of this issue. Few studies have looked at teenaged girls' representations of this vaccination, even though they are the most concerned by it. This qualitative study explored the experiences and representations of HPV vaccination by adolescent girls seeing doctors at least occasionally. We used a written essay question to explore this issue among 101 adolescent girls at six urban medical centers and a semi-structured interview to discuss it in further depth with five of them. The analysis was lexicometric (ALCESTE®) and phenomenological (Interpretative Phenomenological Analysis). These results are organized around four superordinate themes: the teenage girls' factual knowledge about this vaccine, their motives for and obstacles to vaccination, their involvement in this decision, and finally the need for information about and solutions to this issue. Teenage girls know little about this vaccine and are more sensitive to the emotional discourse that surrounds it than to rational knowledge about it. The requirement for parental authorization for this vaccine reinforces the girls' lack of investment. Vaccination programs should integrate the HPV vaccine more thoroughly into general prevention concerning sexual health and should send a strong signal by offering minors anonymous vaccination free of charge, as is already the case in France for requests for contraception, the morning-after pill, elective abortion, and screening and treatment of sexually transmitted infections.

Identifiants

pubmed: 30808568
pii: S0264-410X(19)30215-4
doi: 10.1016/j.vaccine.2019.02.020
pii:
doi:

Substances chimiques

Papillomavirus Vaccines 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

1792-1798

Informations de copyright

Copyright © 2019 Elsevier Ltd. All rights reserved.

Auteurs

Hervé Lefevre (H)

AP-HP, Cochin Hospital, Maison de Solenn, Paris, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, 94805 Villejuif, France; French Clinical Research Group in Adolescent Medicine and Health, France. Electronic address: herve.lefevre@aphp.fr.

Stéphanie Samain (S)

AP-HP, Cochin Hospital, Maison de Solenn, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France.

Nour Ibrahim (N)

AP-HP, Cochin Hospital, Maison de Solenn, Paris, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, 94805 Villejuif, France; French Clinical Research Group in Adolescent Medicine and Health, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Electronic address: nour.ibrahim@aphp.fr.

Christine Fourmaux (C)

French Clinical Research Group in Adolescent Medicine and Health, France; Unité de médecine de l'adolescent CHI Créteil, France. Electronic address: christine.Fourmaux@chicreteil.fr.

Anne Tonelli (A)

French Clinical Research Group in Adolescent Medicine and Health, France; Service de médecine interne pour adolescence, clinque E.Rist, Paris, France. Electronic address: anne.tonelli@fsef.net.

Sébastien Rouget (S)

French Clinical Research Group in Adolescent Medicine and Health, France; Service de pédiatrie Centre Hospitalier Sud-Francilien, Corbeil, France. Electronic address: sebastien.rouget@chsf.fr.

Emmanuelle Mimoun (E)

French Clinical Research Group in Adolescent Medicine and Health, France; CH Marchant, Toulouse, France. Electronic address: emmanuelle.mimoun@ch-marchant.fr.

Renaud De Tournemire (R)

French Clinical Research Group in Adolescent Medicine and Health, France; Unité de Médecine pour Adolescents CHI Poissy St Germain en Laye, France. Electronic address: rdetournemire@chi-poissy-st-germain.fr.

Marie Devernay (M)

French Clinical Research Group in Adolescent Medicine and Health, France; AP-HP, Trousseau Hospital, unité pour adolescents, Paris France. Electronic address: marie.devernay@aphp.fr.

Marie Rose Moro (MR)

AP-HP, Cochin Hospital, Maison de Solenn, Paris, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, 94805 Villejuif, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Electronic address: marie-rose.moro@aphp.fr.

Jonathan Lachal (J)

AP-HP, Cochin Hospital, Maison de Solenn, Paris, France; CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, 94805 Villejuif, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France. Electronic address: jonathan.lachal@gmail.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH